These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1723840)

  • 21. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
    El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
    J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes.
    Martin SK; Thuita-Harun L; Adoyo-Adoyo M; Wasunna KM
    Ann Trop Med Parasitol; 1998 Jul; 92(5):571-7. PubMed ID: 9797830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.
    Maroof A; Brown N; Smith B; Hodgkinson MR; Maxwell A; Losch FO; Fritz U; Walden P; Lacey CN; Smith DF; Aebischer T; Kaye PM
    J Infect Dis; 2012 Mar; 205(5):853-63. PubMed ID: 22301630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis.
    Salotra P; Raina A; Ramesh V
    Trans R Soc Trop Med Hyg; 1999; 93(1):98-101. PubMed ID: 10492802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera.
    Bhaumik SK; Singh MK; Karmakar S; De T
    Mol Biochem Parasitol; 2008 Jun; 159(2):121-9. PubMed ID: 18405984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
    Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
    Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileishmanial IgG and IgE antibodies recognize predominantly carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis.
    Atta AM; Colossi R; Sousa-Atta ML; Jeronimo SM; Nascimento MD; Bezerra GF; Orge G; Carvalho EM
    Mem Inst Oswaldo Cruz; 2004 Aug; 99(5):525-30. PubMed ID: 15543418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy after visceral leishmaniasis: just a coincidence?
    Rombola F; Spinoso A; Bertuccio SN
    Infez Med; 2008 Sep; 16(3):173-4. PubMed ID: 18843217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species.
    Shreffler WG; Burns JM; Badaró R; Ghalib HW; Button LL; McMaster WR; Reed SG
    J Infect Dis; 1993 Feb; 167(2):426-30. PubMed ID: 7678428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
    Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
    Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoantibodies and Leishmania infection].
    Julià Benique MR; Salvá F; Hernández M; Matamoros N
    Med Clin (Barc); 1991 Jun; 97(5):197-8. PubMed ID: 1921552
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of B-cell Epitope of Leishmania donovani and its application in diagnosis of visceral leishmaniasis.
    Jamal F; Dikhit MR; Singh MK; Shivam P; Kumari S; Pushpanjali S; Dubey AK; Kumar P; Narayan S; Gupta AK; Pandey K; Das VNR; Bimal S; Das P; Singh SK
    J Biomol Struct Dyn; 2017 Dec; 35(16):3569-3580. PubMed ID: 27892844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of specific serologic markers in visceral leishmaniasis: anti-p32 antibody response].
    Tebourski F; Louzir H; Ben Ammar-el Gaied A; Ben Ismaïl R; Dellagi K
    Arch Inst Pasteur Tunis; 1994; 71(3-4):447-51. PubMed ID: 8801840
    [No Abstract]   [Full Text] [Related]  

  • 37. Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.
    Saljoughian N; Zahedifard F; Doroud D; Doustdari F; Vasei M; Papadopoulou B; Rafati S
    Parasite Immunol; 2013 Dec; 35(12):397-408. PubMed ID: 23710803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The determination of the species specificity of Leishmania antibodies in different groups of human sera].
    Giboda M; Goncharov DB; Saf'ianova VM; Gracheva LI; Ditrich O
    Med Parazitol (Mosk); 1991; (3):29-32. PubMed ID: 1770880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral leishmaniasis in Somalia. Circulating antibodies as measured by DAT, immunofluorescence and ELISA.
    Shiddo SA; Mohamed AA; Huldt G; Loftenius A; Nilsson L; Jonsson J; Ouchterlony O; Thorstensson R
    Trop Geogr Med; 1995; 47(2):68-73. PubMed ID: 8592766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect Evidence of Circulating Parasite Hapten Immune Complexes in Visceral Leishmaniasis.
    Aparecida de Carvalho C; Fidelis Ferrão T; Mitsuyoshi Hiramoto R; Kelsei Partata A; de Andrade Júnior HF
    J Appl Lab Med; 2019 Nov; 4(3):404-409. PubMed ID: 31659077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.